nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Gastrointestinal pain—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Linezolid—Asthenia—Mometasone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Linezolid—Polyuria—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Linezolid—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Linezolid—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Linezolid—Pruritus—Mometasone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Linezolid—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Linezolid—Anaemia—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Linezolid—Skin disorder—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Linezolid—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Linezolid—Angioedema—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Linezolid—Body temperature increased—Captopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Linezolid—Abdominal pain—Captopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Linezolid—Anorexia—Leflunomide—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Linezolid—Nausea—Pentoxifylline—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Linezolid—Chills—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Linezolid—Vertigo—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Linezolid—Diarrhoea—Mometasone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Linezolid—Hypokalaemia—Prednisone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Linezolid—Leukopenia—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Linezolid—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Linezolid—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Linezolid—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Linezolid—Cough—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Linezolid—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Linezolid—Anorexia—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Linezolid—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Linezolid—Insomnia—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Linezolid—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Linezolid—Paraesthesia—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Linezolid—Dyspnoea—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Linezolid—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Linezolid—Dyspepsia—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Linezolid—Pancreatitis—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Linezolid—Vomiting—Mometasone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Linezolid—Dry mouth—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Linezolid—Sweating increased—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Linezolid—Rash—Mometasone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Linezolid—Asthenia—Captopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Linezolid—Dermatitis—Mometasone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Decreased appetite—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Headache—Mometasone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Insomnia—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Fatigue—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Linezolid—Anaphylactic shock—Lisinopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Linezolid—Pruritus—Captopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Linezolid—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000999	0.000999	CcSEcCtD
Linezolid—Constipation—Leflunomide—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Linezolid—Pain—Leflunomide—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Linezolid—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Linezolid—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Linezolid—Somnolence—Mycophenolic acid—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Linezolid—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Linezolid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000981	0.000981	CcSEcCtD
Linezolid—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Linezolid—Neutropenia—Prednisone—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Linezolid—Body temperature increased—Azathioprine—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Linezolid—Abdominal pain—Azathioprine—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Linezolid—Skin disorder—Lisinopril—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Linezolid—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Linezolid—Diarrhoea—Captopril—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Linezolid—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Linezolid—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Linezolid—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Linezolid—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Linezolid—Fatigue—Mycophenolic acid—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Linezolid—Nausea—Mometasone—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Linezolid—Anorexia—Lisinopril—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Linezolid—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000954	0.000954	CcSEcCtD
Linezolid—Pain—Mycophenolic acid—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Linezolid—Constipation—Mycophenolic acid—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Linezolid—Hyperglycaemia—Prednisone—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Linezolid—Cough—Mycophenolate mofetil—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Linezolid—Dizziness—Captopril—systemic scleroderma	0.000936	0.000936	CcSEcCtD
Linezolid—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000934	0.000934	CcSEcCtD
Linezolid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000932	0.000932	CcSEcCtD
Linezolid—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000929	0.000929	CcSEcCtD
Linezolid—Urticaria—Leflunomide—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Linezolid—Abdominal pain—Leflunomide—systemic scleroderma	0.000922	0.000922	CcSEcCtD
Linezolid—Body temperature increased—Leflunomide—systemic scleroderma	0.000922	0.000922	CcSEcCtD
Linezolid—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Linezolid—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Linezolid—Insomnia—Lisinopril—systemic scleroderma	0.000906	0.000906	CcSEcCtD
Linezolid—Paraesthesia—Lisinopril—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Linezolid—Vomiting—Captopril—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Linezolid—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000896	0.000896	CcSEcCtD
Linezolid—Dyspnoea—Lisinopril—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Linezolid—Rash—Captopril—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Linezolid—Dermatitis—Captopril—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Linezolid—Somnolence—Lisinopril—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Linezolid—Headache—Captopril—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Linezolid—Dyspepsia—Lisinopril—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Linezolid—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Linezolid—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Linezolid—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000878	0.000878	CcSEcCtD
Linezolid—Decreased appetite—Lisinopril—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Linezolid—Eosinophilia—Methotrexate—systemic scleroderma	0.000866	0.000866	CcSEcCtD
Linezolid—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Linezolid—Fatigue—Lisinopril—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Linezolid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Linezolid—Pancreatitis—Methotrexate—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Linezolid—Constipation—Lisinopril—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Linezolid—Pain—Lisinopril—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Linezolid—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Linezolid—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Linezolid—Diarrhoea—Azathioprine—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Linezolid—Haemoglobin—Prednisone—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Linezolid—Nausea—Captopril—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Linezolid—Haemorrhage—Prednisone—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Linezolid—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Linezolid—Asthenia—Leflunomide—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Linezolid—Pancytopenia—Methotrexate—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Linezolid—Pruritus—Leflunomide—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Linezolid—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00082	0.00082	CcSEcCtD
Linezolid—Neutropenia—Methotrexate—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Linezolid—Dizziness—Azathioprine—systemic scleroderma	0.000817	0.000817	CcSEcCtD
Linezolid—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Linezolid—Asthenia—Mycophenolic acid—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Linezolid—Diarrhoea—Leflunomide—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Linezolid—Urticaria—Lisinopril—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Linezolid—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Linezolid—Abdominal pain—Lisinopril—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Linezolid—Body temperature increased—Lisinopril—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Linezolid—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Linezolid—Pruritus—Mycophenolic acid—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Linezolid—Vomiting—Azathioprine—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Linezolid—Pneumonia—Methotrexate—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Linezolid—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Linezolid—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Linezolid—Rash—Azathioprine—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Linezolid—Dermatitis—Azathioprine—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Linezolid—Headache—Azathioprine—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Linezolid—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Linezolid—Dizziness—Leflunomide—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Linezolid—Renal failure—Methotrexate—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Linezolid—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Linezolid—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Linezolid—Stomatitis—Methotrexate—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Linezolid—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Linezolid—Pain—Mycophenolate mofetil—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Linezolid—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Linezolid—Vomiting—Leflunomide—systemic scleroderma	0.000742	0.000742	CcSEcCtD
Linezolid—Dizziness—Mycophenolic acid—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Linezolid—Rash—Leflunomide—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Linezolid—Dermatitis—Leflunomide—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Linezolid—Nausea—Azathioprine—systemic scleroderma	0.000734	0.000734	CcSEcCtD
Linezolid—Headache—Leflunomide—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Linezolid—Erythema—Prednisone—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Linezolid—Asthenia—Lisinopril—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Linezolid—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Linezolid—Pruritus—Lisinopril—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Linezolid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Linezolid—Rash—Mycophenolic acid—systemic scleroderma	0.000702	0.000702	CcSEcCtD
Linezolid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Linezolid—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Linezolid—Headache—Mycophenolic acid—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Linezolid—Pharyngitis—Methotrexate—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Linezolid—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Linezolid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Linezolid—Nausea—Leflunomide—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Linezolid—Vision blurred—Prednisone—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Linezolid—Diarrhoea—Lisinopril—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Linezolid—Anaemia—Prednisone—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Linezolid—Angioedema—Prednisone—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Linezolid—Dizziness—Lisinopril—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Linezolid—Nausea—Mycophenolic acid—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Linezolid—Vertigo—Prednisone—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Linezolid—Vomiting—Lisinopril—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Linezolid—Rash—Lisinopril—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Linezolid—Convulsion—Prednisone—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Linezolid—Dermatitis—Lisinopril—systemic scleroderma	0.000631	0.000631	CcSEcCtD
Linezolid—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Linezolid—Hypertension—Prednisone—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Linezolid—Chills—Methotrexate—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Linezolid—Headache—Lisinopril—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Linezolid—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Linezolid—Erythema—Methotrexate—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Linezolid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000601	0.000601	CcSEcCtD
Linezolid—Dysgeusia—Methotrexate—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Linezolid—Nausea—Lisinopril—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Linezolid—Anaphylactic shock—Prednisone—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Linezolid—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Linezolid—Skin disorder—Prednisone—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Linezolid—Hyperhidrosis—Prednisone—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Linezolid—Vision blurred—Methotrexate—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Linezolid—Anorexia—Prednisone—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Linezolid—Anaemia—Methotrexate—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Linezolid—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Linezolid—Rash—Mycophenolate mofetil—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Linezolid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000553	0.000553	CcSEcCtD
Linezolid—Headache—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Linezolid—Vertigo—Methotrexate—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Linezolid—Insomnia—Prednisone—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Linezolid—Paraesthesia—Prednisone—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Linezolid—Cough—Methotrexate—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Linezolid—Convulsion—Methotrexate—systemic scleroderma	0.000528	0.000528	CcSEcCtD
Linezolid—Dyspepsia—Prednisone—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Linezolid—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Linezolid—Decreased appetite—Prednisone—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Linezolid—Fatigue—Prednisone—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Linezolid—Constipation—Prednisone—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Linezolid—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Linezolid—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Linezolid—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Linezolid—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Linezolid—Anorexia—Methotrexate—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Linezolid—Urticaria—Prednisone—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Linezolid—Body temperature increased—Prednisone—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Linezolid—Abdominal pain—Prednisone—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Linezolid—Insomnia—Methotrexate—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Linezolid—Paraesthesia—Methotrexate—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Linezolid—Dyspnoea—Methotrexate—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Linezolid—Somnolence—Methotrexate—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Linezolid—Decreased appetite—Methotrexate—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Linezolid—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Linezolid—Fatigue—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Linezolid—Asthenia—Prednisone—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Linezolid—Pain—Methotrexate—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Linezolid—Pruritus—Prednisone—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Linezolid—Diarrhoea—Prednisone—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Linezolid—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Linezolid—Urticaria—Methotrexate—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Linezolid—Dizziness—Prednisone—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Linezolid—Vomiting—Prednisone—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Linezolid—Rash—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Linezolid—Dermatitis—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Linezolid—Headache—Prednisone—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Linezolid—Asthenia—Methotrexate—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Linezolid—Nausea—Prednisone—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Linezolid—Pruritus—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—systemic scleroderma	0.00034	0.00034	CcSEcCtD
Linezolid—Dizziness—Methotrexate—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Linezolid—Vomiting—Methotrexate—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Linezolid—Rash—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Linezolid—Headache—Methotrexate—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Linezolid—Nausea—Methotrexate—systemic scleroderma	0.000295	0.000295	CcSEcCtD
